HB
IBB icon

Homrich & Berg’s iShares Biotechnology ETF IBB Stock Holding History

Homrich & Berg’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$238K Buy
1,475
+75
+5% +$12.6K 0.01% 406
2021
Q2 		$229K Buy
+1,400
New +$216K 0.01% 427
2020
Q4 		– Sell
-1,529
Closed -$207K – 402
2020
Q3 		$207K Buy
+1,529
New +$207K 0.01% 315

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Homrich & Berg's IBB Position: Q3 2021 in Review

Homrich & Berg increased its iShares Biotechnology ETF (IBB) stake by 5.4% in Q3 2021, buying an estimated $12.6K and bringing the position to 1,475 shares worth $238K. The position accounts for 0.01% of the portfolio, ranked #406.

Homrich & Berg first reported a position in IBB in Q3 2020 and has held it in 3 quarters since. 855 funds tracked by Wall St. Rank hold IBB as of Q3 2021.

  • Homrich & Berg held 1,475 shares of iShares Biotechnology ETF worth $238K as of Q3 2021.
  • Homrich & Berg bought 75 iShares Biotechnology ETF shares in Q3 2021, an estimated $12.6K.
  • iShares Biotechnology ETF made up 0.01% of Homrich & Berg's portfolio in Q3 2021, its #406 holding.
  • Homrich & Berg first reported a position in iShares Biotechnology ETF in Q3 2020 and has held it in 3 quarters since.
  • 855 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2021.

Based on Homrich & Berg's 13F filing for Q3 2021, filed 8 Dec 2021.